Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Lex Rovner, PhD
CO-FOUNDER & CEO, 64X BIO
When Scientists Become CEOs: What It Takes to Launch a Founder-Led Biotech
San Francisco, California, United States
Steven Rowe, MD
EXECUTIVE VICE PRESIDENT AND CHIEF SCIENTIFIC OFFICER, CYSTIC FIBROSIS FOUNDATION
What Money Can't Buy: The Unique Offerings of Patient Group Investors
Bethesda, Maryland, United States
Nawal Roy
FOUNDER AND CEO, HOLMUSK
Deal Making with AI and Big Data: New Frontiers in Drug Discovery and Development
Carsten Rudolph, PhD
CEO, ETHRIS
Ethris
Planegg, Germany
Howard Rutman, MD, MBA
CHIEF MEDICAL OFFICER, XALUD THERAPEUTICS
Gene Therapy: Let’s Talk about Safety, Baby
Barbara Ryan
BOARD MEMBER, SENIOR ADVISOR TO EY, INDIVIOR, MINK, INVO, SAFECOR PHARMACEUTICAL COMPANIES
Biopharma Dealmaking in Uncertain Times
Norwalk, Connecticut, United States
Gail Ryan
DIRECTOR OF PHARMACEUTICAL TRANSFORMATION, POINT32 HEALTH
Case Study: Launching Successful Gene Therapies in the Value-Based Era
Denise Sabatino, PhD
RESEARCH ASSOCIATE PROFESSOR OF PEDIATRICS, PERELMAN SCHOOL OF MEDICINE, UNIVERSITY OF PENNSYLVANIA AND THE CHILDREN'S HOSPITAL OF PHILADELPHIA
The Future of Non-Viral Gene Therapy: Accelerating Next-Generation Gene Therapies
Philadelphia, Pennsylvania, United States
Placeholder Photo
Cibele Sabido David, PhD
HEAD OF BUSINESS DEVELOPMENT, ZAMBON BIOTECH
Zambon Biotech SA
Cadempino, Ticino, Switzerland
Priyanka Sahasrabudhe, PhD
SR, MANAGER BUSINESS DEVELOPMENT, NAVIGO PROTEINS
Navigo Proteins
Halle (Saale), Germany